| Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser (NCT05335317) | MeLSyTech, Ltd | 2022-04-18 |
| Real-world Evidence Study on the Performance and Safety of Halova Ovules (NCT05654610) | Perfect Care Distribution | 2022-03-01 |
| Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness (NCT05211505) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2022-01-31 |
| Vulvovaginal Atrophy Correction Using Neodymium Laser (NCT04735549) | MeLSyTech, Ltd | 2021-09-01 |
| Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy (NCT05398172) | InMode MD Ltd. | 2021-08-10 |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors (NCT04493333) | University of Arkansas | 2021-06-07 |
| A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy (NCT04159493) | Aspen USA Inc | 2021-06-05 |
| Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal Atrophy (NCT04910906) | Bitop AG | 2021-05-03 |
| Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo (NCT04807894) | Maimonides Medical Center | 2020-11-01 |
| Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial (NCT04079218) | Kerry Murphy | 2020-09-01 |
| Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatment (NCT04868812) | IRCCS San Raffaele | 2019-12-03 |
| Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. (NCT04659668) | Mesoestetic Pharma Group S.L. | 2019-11-11 |
| LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) (NCT04081805) | Federal University of São Paulo | 2019-09-30 |
| Clinical Study to Compare the Efficacy of Erbium-Yag Laser or CO2RE Intimate Laser With Sham (COER) (NCT04039555) | Instituto Palacios | 2019-09-24 |
| Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy (NCT03996603) | University of Alabama at Birmingham | 2019-08-01 |
| A Clinical Clinical Observation of CO2 Fractional Laser in Female Vaginal Repair (NCT04492176) | Xijing Hospital | 2019-08-01 |
| Evaluation of VagiVital® for Treatment of Vaginal Atrophy (NCT03998722) | PepTonic Medical AB | 2019-06-14 |
| Effect of Hybrid Laser 10600+1540 nm on GSM (NCT03956563) | Quanta System, S.p.A. | 2019-05-15 |
| Effect of Laser Therapy on Vaginal Tissue (NCT05898191) | Institute for the Care of Mother and Child, Prague, Czech Republic | 2019-02-01 |
| Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women (NCT03770065) | Viramal Limited | 2018-11-19 |
| Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment (NCT04717245) | University of Sao Paulo General Hospital | 2018-10-25 |
| Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function (NCT03493126) | Ohio State University | 2018-10-15 |
| A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes (NCT03547089) | W. Grant Stevens, MD | 2018-08-01 |
| Radiofrequency and Hybrid Fractional Laser for Vaginal Rejuvenation (NCT03316950) | University of Texas Southwestern Medical Center | 2018-06-15 |
| CO2 Laser in the Treatment of the GSM - (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopause (NCT03939078) | Universidade Federal Fluminense | 2018-04-05 |
| Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation (NCT03520426) | Walden, Jennifer L., M.D.,P.L.L.C. | 2018-03-12 |
| Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause (NCT03754205) | National and Kapodistrian University of Athens | 2018-01-18 |
| Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus (NCT03063684) | Hadassah Medical Organization | 2017-09-01 |
| Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause (NCT03178825) | Sciton | 2017-05-19 |
| Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy (NCT02967510) | ITF Research Pharma, S.L.U. | 2016-10-01 |
| Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects (NCT02747641) | Alma Lasers Inc. | 2016-05-01 |
| A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting (NCT02413008) | ITF Research Pharma, S.L.U. | 2015-10-16 |
| Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness. (NCT02571127) | Farmoquimica S.A. | 2015-10-01 |
| Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments (NCT02704741) | Syneron Medical | 2015-09-01 |
| Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause (NCT02013544) | EndoCeutics Inc. | 2014-02-01 |
| A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin (NCT01975129) | PepTonic Medical AB | 2013-09-01 |
| Efficacy and Safety Of Spil's Estradiol Vaginal Tablet (NCT01753102) | Sun Pharmaceutical Industries Limited | 2012-11-06 |
| VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women (NCT00453089) | Bionovo | 2012-06-01 |
| Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (NCT01987804) | PepTonic Medical AB | 2012-01-01 |
| Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy (NCT01358760) | EndoCeutics Inc. | 2011-06-01 |
| DHEA Against Vaginal Atrophy - Safety Study of 12 Months (NCT01256671) | EndoCeutics Inc. | 2010-12-01 |
| Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation (NCT01899612) | Insel Gruppe AG, University Hospital Bern | 2010-08-01 |
| Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women (NCT01432470) | PepTonic Medical AB | 2010-08-01 |
| Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy. (NCT04574999) | Italfarmaco S.A | 2008-01-25 |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients (NCT00607295) | Seoul National University Hospital | 2007-12-01 |
| Topical DHEA Against Vaginal Atrophy (NCT01846442) | EndoCeutics Inc. | 2007-06-01 |
| DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy (NCT00429806) | CHU de Quebec-Universite Laval | 2006-11-01 |
| Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause (NCT00238732) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-10-01 |